other material
confidence high
sentiment negative
materiality 0.70
Monopar Therapeutics (MNPR): Nasdaq/NYSE listing notice — Monopar receives Nasdaq notice for bid price deficiency; 180 days to regain compliance
Monopar Therapeutics
- Nasdaq notified Monopar on Aug 28, 2023 that bid price closed below $1.00 for 30 consecutive days.
- Company has 180 calendar days (until Feb 26, 2024) to regain compliance with minimum $1.00 bid price.
- To regain compliance, stock must close at $1.00 or more for at least 10 consecutive business days.
- If non-compliant by deadline, Monopar may qualify for a second 180-day cure period subject to other listing standards.